EGFR and central nervous system cancer: -Common in gliomas, especially glioblastoma, leading to aggressive tumor behavior.-EGFRvIII mutation causes continuous activation, driving tumor growth and treatment resistance.-Mutated EGFR promotes tumor cell proliferation and survival.-EGFR alterations make gliomas resistant to conventional treatments.